In a new study from UC San Diego School of Medicine, thousands of fake social media posts tied to COVID-19 and financial scams are found on two popular platforms.
U.S. News & World Report named University of California San Diego School of Medicine a top global university and ranked the divisions of Gastroenterology and Hepatology #1 in the world for research.
University of California San Diego School of Medicine researchers identified a new therapeutic approach in mouse models that halts drug resistance and cancer progression by using an antibody that induces the immune system via macrophages to seek and kill cancer cells.
The San Diego Center for AIDS Research (CFAR) at University of California San Diego has been awarded planning grants to help the federal government achieve its goal of reducing the number of new HIV infections in the United States by 90 percent by 2030.
Researchers at University of California San Diego School of Medicine, in collaboration with local partners, have been awarded a $5 million grant from the National Institutes of Health (NIH) to implement a program of widespread testing for COVID-19 in San Ysidro, focused on pregnant women and children.
UC San Diego School of Medicine has been awarded $9 million to fund research projects using human pluripotent stem cells, CRISPR and human organoids to dissect beta cell defects and create a human cell model of type 1 diabetes aimed at identifying the cellular actions leading to disease onset.
In its first-ever assessment of biomedical institutions around the world, based upon published research in a targeted set of high-quality scientific journals, the 2019 Nature Index ranked University of California San Diego ninth among the top 200 institutions in biomedical sciences worldwide.
J. Silvio Gutkind elected to National Academy of Medicine for his contributions to the understanding of cancer signaling networks and pioneering the study of the PIK3CA-mTOR signaling circuitry in head and neck cancer.
UC San Diego Health will be part of the Phase III national AstraZeneca clinical trial that will recruit up to 30,000 participants at multiple sites across the country to assess the safety and efficacy of a vaccine to prevent COVID-19.
Health Media Contacts
Find the best contact for health-related media inquiries.
